CLBS12

Drug identity checked against registry records

Also recorded as CD34+ cells

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)NCT02501018LSTAPhase 2Completed2022-05-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.